Hosted on MSN3d
Study Finds Exenatide Not Beneficial for Parkinson Disease
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, ...
cambridgeindependent11h
Arecor lets Tetris go as revenue rises
A full-year 2024 trading update for Arecor Therapeutics shows revenue was up to £5.1million (2023: £4.6m) while cash and cash ...
Forbes1y
FDA Approved A New Weight Loss Drug Zepbound. Here’s What To Know And Expect
CARLSBAD, CA-NOV 30TH: Mounjaro injection pen on display at Rachel Graham's ... mimicking two naturally occurring hormones in the body, glucagon-like peptide-1 (GLP-1) and glucose-dependent ...
pharmaphorum1d
FDA knocks back Zealand's dasiglucagon once again
Another drugs that may be used off-label for GHI include Xeris' Gvoke brand of glucagon in pre-filled syringe and pen injector formulations, which was approved in 2019 as a hypoglycaemia rescue ...
Medscape27d
Glucagon Prescriptions Still Fall Short of Meeting Demand
Glucagon prescriptions for severe hypoglycemia in Medicaid initially decreased from 2012 to 2018 but increased between 2019 and 2023 following the introduction of newer products. Glucagon ...
pharmaphorum6d
CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar
In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...